These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. A global strategy for prevention and detection of blood doping with erythropoietin and related drugs. Cazzola M Haematologica; 2000 Jun; 85(6):561-3. PubMed ID: 10870110 [No Abstract] [Full Text] [Related]
25. [The 1988 Olympic Games--a turning-point in the doping problem?]. Björkhem I; Ljungqvist A; Sjöqvist F Lakartidningen; 1989 Mar; 86(13):1149-51. PubMed ID: 2704264 [No Abstract] [Full Text] [Related]
26. [National and international work against doping]. Lereim I Tidsskr Nor Laegeforen; 2001 May; 121(13):1563. PubMed ID: 11446036 [No Abstract] [Full Text] [Related]
27. [The athlete with asthma and the new 2010 anti-doping regulations. Less work to change a limited therapy]. Drobnic F Arch Bronconeumol; 2010 May; 46(5):280-1. PubMed ID: 20092924 [No Abstract] [Full Text] [Related]
28. A level playing field? Nature; 2008 Aug; 454(7205):667. PubMed ID: 18685647 [No Abstract] [Full Text] [Related]
29. Rheumatological prescribing in athletes: a review of the new World Anti-Doping Agency guidelines. Smith R; Barnsley L; Kannangara S; Mace A Rheumatology (Oxford); 2004 Dec; 43(12):1473-5. PubMed ID: 15292526 [TBL] [Abstract][Full Text] [Related]
30. Doping in sport: challenges for medicine, science and ethics. Murray TH J Intern Med; 2008 Aug; 264(2):95-8. PubMed ID: 18702749 [No Abstract] [Full Text] [Related]
31. Back to the game: how Congress can help sports leagues shift the focus from steroids to sports. Saka JM J Contemp Health Law Policy; 2007; 23(2):341-63. PubMed ID: 17642385 [No Abstract] [Full Text] [Related]
32. [Doctors belonging to the Senegalese Association of Sport Medicine and doping in sports: survey on knowledge and attitudes]. Dièye AM; Diallo B; Fall A; Ndiaye M; Cissè F; Faye B Sante; 2005; 15(3):167-70. PubMed ID: 16207578 [TBL] [Abstract][Full Text] [Related]
33. The world anti-doping program and the primary care physician. Hilderbrand RL Pediatr Clin North Am; 2007 Aug; 54(4):701-11, x-xi. PubMed ID: 17723872 [TBL] [Abstract][Full Text] [Related]
34. Rogue athletes and recombinant DNA technology: challenges for doping control. Azzazy HM; Mansour MM Analyst; 2007 Oct; 132(10):951-7. PubMed ID: 17893796 [TBL] [Abstract][Full Text] [Related]
35. Doping in athletes--an update. De Rose EH Clin Sports Med; 2008 Jan; 27(1):107-30, viii-ix. PubMed ID: 18206571 [TBL] [Abstract][Full Text] [Related]
36. Comparative analysis of European legislation on doping. Cecchi R; Cipolloni L Med Law; 1995; 14(7-8):571-9. PubMed ID: 8668005 [TBL] [Abstract][Full Text] [Related]
37. The need for antidoping research. Cawley A Mol Ther; 2005 Feb; 11(2):177. PubMed ID: 15668129 [No Abstract] [Full Text] [Related]
38. [Doping in high-level athletes]. Chalchat B Ann Pharm Fr; 2002 Sep; 60(5):303-9. PubMed ID: 12378138 [TBL] [Abstract][Full Text] [Related]
39. Distribution of caffeine levels in urine in different sports in relation to doping control before and after the removal of caffeine from the WADA doping list. Van Thuyne W; Delbeke FT Int J Sports Med; 2006 Sep; 27(9):745-50. PubMed ID: 16586337 [TBL] [Abstract][Full Text] [Related]
40. [Sport and drugs--when is there a risk for doping? All beta blockaders and diuretics are now prohibited]. Eriksson B; Sahlström S; Waltersson JO Lakartidningen; 1989 Mar; 86(13):1187, 1189-90. PubMed ID: 2564900 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]